MoneyWorks4Me

Mangalam Drugs & Organics informs about revised disclosure

29 Apr 2026 Evaluate
Mangalam Drugs & Organics has informed that the exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 29, 2026 for Aditya Ramniwas Dhoot.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..